Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1079


CNS Year in Review: 2001


Description: This Market Brief sets out the sales figures of the leading CNS drugs for 2001, together with the leading events, be they clinical trial results, product launches, patent expiries or court room battles which have helped to shape the market throughout the year. The major CNS disease markets are examined, namely Alzheimer’s disease, anticonvulsants, antidepressants, antipsychotics, migraine, multiple sclerosis, pain, and Parkinson’s disease. This brief paints a preliminary picture of the 2001 CNS market before the full yearly breakdowns have become available. Furthermore, it also provides a brief overview of the current trends in the CNS market and how individual markets may develop. The sales figures set out in this report are obtained from one of three sources. Priority was given to published 2001 results, however most of the figures presented are derived from primary research regarding quarterly sales, which were then projected to give a full year figure. However, in some cases it was not possible to obtain such figures. In these cases, the most up to date forecasts from Datamonitor’s reports were taken.


Contents:
TABLE OF CONTENTS





INTRODUCTION


2001 global CNS market


ALZHEIMER’S DISEASE MARKET


2001 global market


2001 product highlights


Aricept: defending its position


Reminyl: establishing itself as a major player


ANTICONVULSANTS MARKET


2001 global market


2001 product highlights


Neurontin: driving its revenue growth through neuropathic pain and other novel markets


Lamictal: attempting to keep pace with Neurontin


ANTIDEPRESSANT MARKET


2001 global market


2001 product highlights


Prozac: market collapse following US generic competition


Prozac Weekly/Remeron SolTab: novel formulations underpin strategies to prolong product lifecycles


Paxil: further indications drive growth but generic substitution threatens future


Zoloft: gearing up for additional licenses to challenge Paxil


ANTIPSYCHOTIC MARKET


2001 global market


2001 product highlights


Zyprexa: further growth expanded its dominant position


Seroquel: raising its game


Risperdal: innovating its class through product reformulation


Geodon: Pfizer finally enters the US market


MIGRAINE MARKET


2001 global market


2001 product highlights


Imigran: development of innovative marketing strategies


Zomig: driving sales through reformulation


MULTIPLE SCLEROSIS MARKET


2001 global market


2001 product highlights


Avonex: pivotal trials driving revenue growth


Betaseron: attempting to prove US regulators wrong


PAIN MARKET


2001 global market


2001 product highlights


Celebrex: relying on DTC and clinical data to stimulate revenues following cardiovascular fiasco


Vioxx: undermined by clincial trial data


PARKINSON’S DISEASE MARKET


2001 global market


2001 product highlights


Comtan: driven by North American revenues


ReQuip: clinical trial data expanding patients and


BIBLIOGRAPHY


References


Websites


DATAMONITOR HEALTHCARE




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1079

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 28/11/2009 01:30:32
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
CNS Year in Review: 2001
Web Address:
http://www.researchandmarkets.com/reports/1079
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €1,048.00 + EUR€ 50.00 Shipping/Handling *
Electronic €1,007.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 28/11/2009 01:30:32

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)